Market Tracker

07/27 5:16pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

26.71
Delayed Data
As of 3:59pm ET
 +0.80 / +3.09%
Today’s Change
23.85
Today|||52-Week Range
43.63
-37.56%
Year-to-Date

Today’s Trading

Previous close25.91
Today’s open26.00
Day’s range25.91 - 26.73
Volume515,789
Average volume (3 months)618,693
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)-40.48%
Earnings growth (this year)-28.89%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+22.71%
P/E ratio86.9
Price/Sales3.79
Price/Book1.85

Competitors

 Today’s
change
Today’s
% change
SRPTSarepta Therapeutics...+0.28+1.15%
DEPODepomed Inc-0.37-1.94%
ACHNAchillion Pharmaceut...+0.01+0.12%
LCILannett Company Inc+0.85+2.79%
Data as of 4:01pm ET, 07/27/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.24
Annual revenue (last year)$492.7M
Annual profit (last year)$11.1M
Net profit margin2.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Head-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts